Actively Recruiting
ACT-GLOBAL Adaptive Platform Trial for Stroke
Led by The George Institute · Updated on 2024-11-21
20000
Participants Needed
2
Research Sites
518 weeks
Total Duration
On this page
Sponsors
T
The George Institute
Lead Sponsor
U
University of Calgary
Collaborating Sponsor
AI-Summary
What this Trial Is About
Stroke is causing 6.6 million deaths and is a major cause of disability worldwide in 2019. There remains an urgent need for interventions that improve outcomes which can be implemented with wide applicability for stroke. ACT-GLOBAL is a multi-factorial, multi-arm, multi-stage, randomised, global adaptive platform trial for stroke, aiming to identify the treatment/s associated with the highest chance of improving outcome in stroke patients. In ACT-GLOBAL multiple questions will be evaluated simultaneously and sequentially as data accrues and can evaluate interactions between different treatment options.
CONDITIONS
Official Title
ACT-GLOBAL Adaptive Platform Trial for Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Clinical diagnosis of stroke
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The George Institute for Global Health
Sydney, New South Wales, Australia, 2005
Actively Recruiting
2
University of Calgary
Calgary, Alberta, Canada, T2N 1N4
Actively Recruiting
Research Team
X
Xiaoying Chen, PhD
CONTACT
B
Bijoy Menon, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here